Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Gemifloxacin mesylate

Base Information Edit
  • Chemical Name:Gemifloxacin mesylate
  • CAS No.:204519-65-3
  • Deprecated CAS:204519-65-3,214346-13-1
  • Molecular Formula:C19H24FN5O7S
  • Molecular Weight:485.4866
  • Hs Code.:
  • NSC Number:759252
  • UNII:X4S9F8RL01
  • DSSTox Substance ID:DTXSID7045948
  • NCI Thesaurus Code:C47548
  • RXCUI:402429
  • ChEMBL ID:CHEMBL1200621
  • Mol file:204519-65-3.mol
Gemifloxacin mesylate

Synonyms:7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid;Factive;gemifloxacin;gemifloxacin mesylate;LB 20304;LB-20304;LB20304;SB 265805;SB-265805;SB265805

Suppliers and Price of Gemifloxacin mesylate
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • American Custom Chemicals Corporation
  • GEMIFLOXACIN MESILATE 95.00%
  • 1G
  • $ 1904.70
  • American Custom Chemicals Corporation
  • GEMIFLOXACIN MESILATE 95.00%
  • 100MG
  • $ 1593.90
  • American Custom Chemicals Corporation
  • GEMIFLOXACIN MESILATE 95.00%
  • 10MG
  • $ 704.55
Total 20 raw suppliers
Chemical Property of Gemifloxacin mesylate Edit
Chemical Property:
  • Vapor Pressure:3.36E-17mmHg at 25°C 
  • Boiling Point:638.9 °C at 760 mmHg 
  • Flash Point:340.2 °C 
  • Hydrogen Bond Donor Count:3
  • Hydrogen Bond Acceptor Count:13
  • Rotatable Bond Count:5
  • Exact Mass:485.13804746
  • Heavy Atom Count:33
  • Complexity:817
Purity/Quality:

99%, *data from raw suppliers

GEMIFLOXACIN MESILATE 95.00% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Canonical SMILES:CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F.CS(=O)(=O)O
  • Isomeric SMILES:CO/N=C/1\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F.CS(=O)(=O)O
  • Recent EU Clinical Trials:A Phase IIIb, Randomized, Double-Blind, Multicenter, Parallel Group Study
  • Uses Antibacterial.
Post RFQ for Price